It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Multiplex imaging technologies are increasingly used for single-cell phenotyping and spatial characterization of tissues; however, transparent methods are needed for comparing the performance of platforms, protocols and analytical pipelines. We developed a python software, mplexable, for reproducible image processing and utilize Jupyter notebooks to share our optimization of signal removal, antibody specificity, background correction and batch normalization of the multiplex imaging with a focus on cyclic immunofluorescence (CyCIF). Our work both improves the CyCIF methodology and provides a framework for multiplexed image analytics that can be easily shared and reproduced.
An approach for tissue image analysis applicable to highly multiplexed immunofluorescence imaging of the spatial distribution of multiple protein biomarkers is proposed, here applied to the analysis of multiplex IF using the multiplex imaging platform, CyCIF.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Oregon Health and Science University, Department of Biomedical Engineering, School of Medicine, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690); Oregon Health and Science University, Knight Cancer Institute, School of Medicine, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690)
2 Oregon Health and Science University, Department of Biomedical Engineering, School of Medicine, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690)
3 Oregon Health and Science University, Cancer Early Detection Advanced Research Center, School of Medicine, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690)